Literature DB >> 11519287

Antiviral therapy: respiratory infections, chronic hepatitis.

B I Asmar1, N M Abdel-Haq.   

Abstract

This review focuses on the activity, clinical pharmacology, and clinical indications of antiviral agents used in the management of influenza, respiratory syncytial virus infections, and chronic hepatitis B and C. Two neuraminidase inhibitors, a new class of antiviral agents, were recently approved for the treatment of influenza A and B in children.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11519287     DOI： 10.1007/BF02752278

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   5.319


  32 in total

Review 1.  Treatment of hepatitis C virus infection in children.

Authors:  R Francavilla; G Mieli-Vergani
Journal:  Can J Gastroenterol       Date:  2000 Jul-Aug       Impact factor: 3.522

Review 2.  Interferons: pleiotropic cellular modulators.

Authors:  E C Borden
Journal:  Clin Immunol Immunopathol       Date:  1992-01

3.  Topic and systemic administration of natural alfa interferon in the treatment of female and male HPV genital infections.

Authors:  P Stentella; A Frega; F Di Renzi; P L Palazzetti; A Pachì
Journal:  Clin Exp Obstet Gynecol       Date:  1996       Impact factor: 0.146

Review 4.  Updated treatment for influenza A and B.

Authors:  N J Montalto; K D Gum; J V Ashley
Journal:  Am Fam Physician       Date:  2000-12-01       Impact factor: 3.292

Review 5.  Antiviral therapy for patients with chronic hepatitis C.

Authors:  J Heathcote
Journal:  Semin Liver Dis       Date:  2000       Impact factor: 6.115

6.  Safety, tolerance, and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection.

Authors:  E Connor; S Morrison; J Lane; J Oleske; R L Sonke; J Connor
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

7.  Influenza virus M2 protein has ion channel activity.

Authors:  L H Pinto; L J Holsinger; R A Lamb
Journal:  Cell       Date:  1992-05-01       Impact factor: 41.582

8.  Anti-influenza A virus activity of amantadine hydrochloride and rimantadine hydrochloride in ferret tracheal ciliated epithelium.

Authors:  D B Burlington; G Meiklejohn; S R Mostow
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

9.  Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function.

Authors:  V W Horadam; J G Sharp; J D Smilack; B H McAnalley; J C Garriott; M K Stephens; R C Prati; D C Brater
Journal:  Ann Intern Med       Date:  1981-04       Impact factor: 25.391

10.  Emergence and apparent transmission of rimantadine-resistant influenza A virus in families.

Authors:  F G Hayden; R B Belshe; R D Clover; A J Hay; M G Oakes; W Soo
Journal:  N Engl J Med       Date:  1989-12-21       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.